Page last updated: 2024-08-23

danazol and ecallantide

danazol has been researched along with ecallantide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Firszt, R; Frank, MM1
Bork, K1
Bork, K; Bowen, T; Boysen, H; Craig, T; Farkas, H; Grumach, A; Katelaris, CH; Lockey, R; Longhurst, H; Lumry, W; Magerl, M; Martinez-Saguer, I; Maurer, M; Nast, A; Pawankar, R; Pürsün, EA; Ritchie, B; Zuraw, B1
Banerji, A; Bernstein, JA; Busse, P; Christiansen, S; Craig, T; Davis-Lorton, M; Frank, MM; Li, HH; Lumry, WR; Riedl, M; Zuraw, B1

Reviews

2 review(s) available for danazol and ecallantide

ArticleYear
An overview of novel therapies for acute hereditary angioedema.
    American journal of clinical dermatology, 2010, Dec-01, Volume: 11, Issue:6

    Topics: Acute Disease; Adrenergic beta-Antagonists; Androgens; Antifibrinolytic Agents; Bradykinin; Bradykinin Receptor Antagonists; Complement C1 Inhibitor Protein; Danazol; Hereditary Angioedema Type III; Hereditary Angioedema Types I and II; Hormone Antagonists; Humans; Kallikreins; Peptides; Tranexamic Acid

2010
Current management options for hereditary angioedema.
    Current allergy and asthma reports, 2012, Volume: 12, Issue:4

    Topics: Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Danazol; Disease Management; Humans; Oxandrolone; Peptides; Plasma; Recombinant Proteins; Stanozolol

2012

Other Studies

2 other study(ies) available for danazol and ecallantide

ArticleYear
[WAO Guideline for the Management of Hereditary Angioedema].
    Arerugi = [Allergy], 2015, Volume: 64, Issue:9

    Topics: Allergy and Immunology; Angioedemas, Hereditary; Bradykinin B2 Receptor Antagonists; Child; Child, Preschool; Complement C1 Inhibitor Protein; Danazol; Diagnosis, Differential; Evidence-Based Medicine; Female; Humans; International Cooperation; Kallikreins; Male; Patient Care Planning; Peptides; Practice Guidelines as Topic; Pregnancy; Recombinant Proteins; Social Support

2015
Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
    Pediatrics, 2016, Volume: 138, Issue:5

    Topics: Adolescent; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Bradykinin; Child; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Genetic Testing; Humans; Patient Care Team; Patient Education as Topic; Peptides; Recombinant Proteins; Tranexamic Acid

2016